Characterization of transient expression system for retroviral vector production

Journal of Bioscience and Bioengineering

Volumn 101, Issue 4, 2006, Pages 361-368

  Hotta, Akitsu ^a   Saito, Yoshikazu ^a   Kyogoku, Kenji ^b   Kawabe, Yoshinori ^a   Nishijima, Ken ichi ^a   Kamihira, Masamichi ^a   Iijima, Shinji ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b KANEKA CORPORATION   (Japan)

Author keywords

gene therapy; murine stem cell virus (MSCV); Q vector; retroviral vector; transient transfection

Indexed keywords

CELLS; GENES; PROTEINS; RNA; TOXICITY;

GENE THERAPY; MURINE STEM CELL VIRUS (MSCV); Q-VECTOR; RETROVIRAL VECTORS; TRANSIENT TRANSFECTION;

VIRUSES;

PLASMID VECTOR; RETROVIRUS VECTOR; VIRUS PROTEIN; VIRUS RNA; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; RNA TRANSCRIPTION; TRANSGENE; VIRUS PARTICLE; VIRUS TITRATION; VIRUS TRANSCRIPTION; ANIMAL; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; GENE THERAPY; GENE VECTOR; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; PLASMID; RETROVIRUS;

MURINAE;

ANIMALS; CELL LINE; GENE THERAPY; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; MICE; NIH 3T3 CELLS; PLASMIDS; RETROVIRIDAE; RNA, MESSENGER; RNA, VIRAL; TRANSFECTION; TRANSGENES;

EID: 33745786870     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.101.361     Document Type: Article

References (36)

1. Miller A.D. Development and applications of retroviral vectors. In: Coffin J.M., Hughes S.H., and Varmus H.E. (Eds). Retroviruses, Chap. 9 (2002), Cold Spring Harbor Laboratory Press, New York
2. Weber E., Anderson W.F., and Kasahara N. Recent advances in retrovirus vector-mediated gene therapy: teaching an old vector new tricks. Curr. Opin. Mol. Ther. 3 (2001) 439-453
3. Lin S., Gaiano N., Culp P., Burns J.C., Friedmann T., Yee J.K., and Hopkins N. Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Scienc 265 (1994) 666-669
4. Chan A.W., Chong K.Y., Martinovich C., Simerly C., and Schatten G. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Scienc 291 (2001) 309-312
5. Kamihira M., Ono K., Esaka K., Nishijima K., Kigaku R., Komatsu H., Yamashita T., Kyogoku K., and Iijima S. High-level expression of single-chain Fv-Fc fusion protein in serum and egg white of genetically manipulated chickens by using a retroviral vector. J. Virol 79 (2005) 10864-10874
6. VandenDriessche T., Collen D., and Chuah M.K. Biosafety of onco-retroviral vectors. Curr. Gene Ther 3 (2003) 501-515
7. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. US 90 (1993) 8033-8037
8. Merten O.W. State-of-the-art of the production of retroviral vectors. J. Gene Med. 6 (2004) S105-S124
9. Naviaux R.K., Costanzi E., Haas M., and Verma I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol 70 (1996) 5701-5705
10. Landau N.R., and Littman D.R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol 66 (1992) 5110-5113
11. Pear W.S., Nolan G.P., Scott M.L., and Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. US 90 (1993) 8392-8396
12. Finer M.H., Dull T.J., Qin L., Farson D., and Roberts M.R. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Bloo 83 (1994) 43-50
13. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., and Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23 (1995) 628-633
14. Olsen J.C., and Sechelski J. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum. Gene Ther 6 (1995) 1195-1202
15. Zhang H., Duan L.X., Dornadula G., and Pomerantz R.J. Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies. J. Virol. 69 (1995) 3929-3932
16. Julius M.A., Yan Q., Zheng Z., and Kitajewski J. Q vectors, bicistronic retroviral vectors for gene transfer. Biotechnique 28 (2000) 702-708
17. Cherry S.R., Biniszkiewicz D., van Parijs L., Baltimore D., and Jaenisch R. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell. Biol 20 (2000) 7419-7426
18. Mizuarai S., Ono K., Yamaguchi K., Nishijima K., Kamihira M., and Iijima S. Production of transgenic quails with high frequency of germ-line transmission using VSV-G pseudotyped retroviral vector. Biochem. Biophys. Res. Commun 286 (2001) 456-463
19. Higashikawa F., and Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virolog 280 (2001) 124-131
20. Hotta A., Kamihira M., Itoh K., Morched M., Kawabe Y., Ono K., Matsumoto H., Nishijima K., and Iijima S. Production of anti-CD2 chimeric antibody by recombinant animal cells. J. Biosci. Bioeng 98 (2004) 298-303
21. Ono K., Kamihira M., Kuga Y., Matsumoto H., Hotta A., Itoh T., Nishijima K., Nakamura N., Matsuda H., and Iijima S. Production of anti-prion scFv-Fc fusion proteins by recombinant animal cells. J. Biosci. Bioeng 95 (2003) 231-238
22. Mizuarai S., Ono K., You J., Kamihira M., and Iijima S. Protamine-modified DDAB lipid vesicles promote gene transfer in the presence of serum. J. Biochem. (Tokyo 129 (2001) 125-132
23. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol 26 (1967) 365-369
24. Chernajovsky Y., Gould D.J., and Podhajcer O.L. Gene therapy for autoimmune diseases: quo vadis?. Nat. Rev. Immunol. 4 (2004) 800-811
25. Yang S., Delgado R., King S.R., Woffendin C., Barker C.S., Yang Z.Y., Xu L., Nolan G.P., and Nabel G.J. Generation of retroviral vector for clinical studies using transient transfection. Hum. Gene Ther. 10 (1999) 123-132
26. Yap M.W., Kingsman S.M., and Kingsman A.J. Effects of stoichiometry of retroviral components on virus production. J. Gen. Virol 81 (2000) 2195-2202
27. Bajgelman M.C., Costanzi-Strauss E., and Strauss B.E. Exploration of critical parameters for transient retrovirus production. J. Biotechnol. 103 (2003) 97-106
28. Ory D.S., Neugeboren B.A., and Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. US 93 (1996) 11400-11406
29. Chittenden T., Frey A., and Levine A.J. Regulated replication of an episomal simian virus 40 origin plasmid in COS7 cells. J. Virol 65 (1991) 5944-5951
30. Paillart J.C., Shehu-Xhilaga M., Marquet R., and Mak J. Dimerization of retroviral RNA genomes: an inseparable pair. Nat. Rev. Microbiol 2 (2004) 461-472
31. Huthoff H., and Berkhout B. Two alternating structures of the HIV-1 leader RNA. RN 7 (2001) 143-157
32. Ooms M., Huthoff H., Russell R., Liang C., and Berkhout B. A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J. Virol 78 (2004) 10814-10819
33. D'souza V., and Summers M.F. Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature 431 (2004) 586-590
34. Mark-Danieli M., Laham N., Kenan-Eichler M., Castiel A., Melamed D., Landau M., Bouvier N.M., Evans M.J., and Bacharach E. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. J. Virol. 79 (2005) 7756-7767
35. Lee S.H., and Vidal S.M. Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res 12 (2002) 527-530
36. Mibayashi M., Nakad K., and Nagata K. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol. Immunol 46 (2002) 29-36